Artelo Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -3,149 | -2,379 | -3,812 | -1,195 |
EBIT | -3,150 | -2,379 | -3,812 | -1,195 |
Net Income | -3,221 | -2,372 | -3,778 | -1,132 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -488 | -1,597 | -2,567 | -1,974 |
Cash | 2,066 | 746 | 2,338 | 4,357 |
Basic Shares | 574 | 3,281 | 539 | 3,228 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -10,108 | -9,930 | -10,285 | -7,443 |
EBIT | -10,108 | -9,930 | -10,287 | -7,441 |
Net Income | -9,826 | -9,289 | -10,083 | -7,437 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,350 | -8,207 | -8,008 | -6,141 |
Cash | 2,338 | 2,815 | 6,888 | 6,629 |
Basic Shares | 3,223 | 2,960 | 472 | 207 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$5.61 |
2025-03-31 | -$0.72 |
2024-12-31 | -$1.17 |
2024-09-30 | -$0.34 |
